Gold Sodium Thiomalate
(VXIHRIQNJCRFQX-UHFFFAOYSA-K)
Structure
- SMILES
- [O-]C(=O)CC(C(=O)[O-])[S-].[Na+].[Na+].[Au+]
- Type(s)
- Approved; Investigational
- ATC code(s)
- M01CB01
- Molecular Formula:
- C4H3AuNa2O4S
- Molecular Weight:
- 390.075
- Log P:
- -3.2107
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 0
- TPSA:
- 80.26
- CAS Number(s):
- 12244-57-4; 74916-57-7
Synonym(s)
1.
Gold Sodium Thiomalate
2.
Aurothiomalate
3.
Gold Thiomalate
4.
Sodium Gold Thiomalate
5.
Aurolate
6.
Gold Disodium Thiomalate, Monohydrate
7.
Gold Thiomalic Acid
8.
Mercaptobutanedioic Acid Monogold(1+) Sodium Salt
9.
Miocrin
10.
Miocrisin
11.
Monogold (1+) Disodium Thiomalate
12.
Myochrysine
13.
Myocrisin
14.
Myocrysine
15.
Sodium Aurothiomalate
16.
Sodium Thiomalatoaurate
17.
Tauredon
18.
Aurothiomalate, Sodium
19.
Gold Thiomalate, Sodium
20.
Sodium Thiomalate, Gold
21.
Thiomalate, Gold
22.
Thiomalatoaurate, Sodium
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Hypotension | FAERS: 2 | 11669157 | CTD US FAERS |
| 2 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 3 | Ammonia increased | FAERS: 1 | US FAERS | |
| 4 | Ascites | FAERS: 1 | US FAERS | |
| 5 | Autoimmune hepatitis | FAERS: 1 | US FAERS | |
| 6 | Blood cholesterol increased | FAERS: 1 | US FAERS | |
| 7 | Cachexia | FAERS: 1 | US FAERS | |
| 8 | Chest Pain | FAERS: 1 | US FAERS | |
| 9 | Colitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Dizziness | FAERS: 1 Canada Vigilance: 1 | 11669157 | CTD Canada Vigilance US FAERS |
| 11 | Hepatic Encephalopathy | FAERS: 1 | US FAERS | |
| 12 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 13 | Nausea | FAERS: 1 Canada Vigilance: 1 | 11669157 | CTD Canada Vigilance US FAERS |
| 14 | Pancytopenia | FAERS: 1 | US FAERS | |
| 15 | Pneumonitis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | Purpura | FAERS: 1 | US FAERS | |
| 17 | Syncope | FAERS: 1 | 11669157 | CTD US FAERS |
| 18 | Abdominal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Adenoma | 104418 | CTD | |
| 20 | Albuminuria | 821403 10357114 | CTD | |
| 21 | Alveolitis | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Angina Pectoris | 11669157 | CTD | |
| 23 | Arthralgia | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Arthritis | Canada Vigilance: 2 | Canada Vigilance | |
| 25 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Autoimmune Diseases | 3097874 19077085 | CTD | |
| 27 | Blepharoptosis | 6419855 | CTD | |
| 28 | Cardiac Arrest | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Chills | Canada Vigilance: 2 | Canada Vigilance | |
| 30 | Chorea | Canada Vigilance: 1 | Canada Vigilance | |
| 31 | Conjunctivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 32 | Cyanosis | Canada Vigilance: 1 | Canada Vigilance | |
| 33 | Dacryostenosis congenital | Canada Vigilance: 1 | Canada Vigilance | |
| 34 | Dermatitis | Canada Vigilance: 4 | Canada Vigilance | |
| 35 | Diabetes Mellitus | Canada Vigilance: 1 | Canada Vigilance | |
| 36 | Diplopia | Canada Vigilance: 1 | 6419855 | CTD Canada Vigilance |
| 37 | Drug Eruptions | 11669157 | CTD | |
| 38 | Drug ineffective | Canada Vigilance: 2 | Canada Vigilance | |
| 39 | Duodenal Ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 40 | Dysgeusia | Canada Vigilance: 1 | Canada Vigilance | |
| 41 | Enterocolitis | Canada Vigilance: 1 | Canada Vigilance | |
| 42 | Eosinophilia | Canada Vigilance: 2 | Canada Vigilance | |
| 43 | Erythema | Canada Vigilance: 3 | Canada Vigilance | |
| 44 | Exanthema | 4216306 6419855 6442055 | CTD | |
| 45 | Expired product administered | Canada Vigilance: 1 | Canada Vigilance | |
| 46 | Fatigue | Canada Vigilance: 2 | Canada Vigilance | |
| 47 | Flushing | Canada Vigilance: 2 | 11669157 | CTD Canada Vigilance |
| 48 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 49 | Hepatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 50 | Hypersensitivity | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | Infection | Canada Vigilance: 1 | Canada Vigilance | |
| 52 | Jaundice, Obstructive | 1440084 | CTD | |
| 53 | Lethargy | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | Leukopenia | Canada Vigilance: 2 | Canada Vigilance | |
| 55 | Limb injury | Canada Vigilance: 1 | Canada Vigilance | |
| 56 | Malaise | Canada Vigilance: 3 | Canada Vigilance | |
| 57 | Meningitis | Canada Vigilance: 1 | Canada Vigilance | |
| 58 | Myasthenia Gravis | 6419855 | CTD | |
| 59 | Myocardial Infarction | Canada Vigilance: 2 | Canada Vigilance | |
| 60 | Nephrosis | 104418 | CTD | |
| 61 | Nephrotic Syndrome | Canada Vigilance: 2 | Canada Vigilance | |
| 62 | Neutropenia | Canada Vigilance: 2 | Canada Vigilance | |
| 63 | Occupational exposure to product | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Oropharyngeal pain | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Petechiae | Canada Vigilance: 2 | Canada Vigilance | |
| 66 | Pharyngitis | Canada Vigilance: 2 | Canada Vigilance | |
| 67 | Pregnancy | Canada Vigilance: 1 | Canada Vigilance | |
| 68 | Presyncope | Canada Vigilance: 5 | Canada Vigilance | |
| 69 | Proteinuria | Canada Vigilance: 3 | 2782197 4216306 | CTD Canada Vigilance |
| 70 | Pruritus | Canada Vigilance: 6 | 1440084 4216306 6442055 | CTD Canada Vigilance |
| 71 | Pulmonary Fibrosis | Canada Vigilance: 2 | Canada Vigilance | |
| 72 | Rash papulosquamous | Canada Vigilance: 1 | Canada Vigilance | |
| 73 | Rheumatoid Arthritis | Canada Vigilance: 1 | Canada Vigilance | |
| 74 | Stomatitis | Canada Vigilance: 3 | 821403 | CTD Canada Vigilance |
| 75 | Swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 76 | Thrombocytopenia | Canada Vigilance: 9 | Canada Vigilance | |
| 77 | Urticaria | Canada Vigilance: 2 | Canada Vigilance | |
| 78 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.